Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
LKFT: Lakefront Biotherapeutics N.V. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
LKFT
The Story
LKFT
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+0.0% / yr
Operating margin
57.1%
ROIC
18.2%
Financially safe
Stretched
Debt / equity
0.00×
Interest coverage
0.0×
Current ratio
30.48×
Valuation
Unrated
P/E ratio
3.2×
Lakefront Biotherapeutics N.V.
LKFT
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Lakefront Biotherapeutics N.V.
LKFT
NASDAQ
·
USD
·
Closed
$27.21
−1.56%
$27.21
−$0.43 (1.56%)
52W Range
7th
pctl
Volume
1.02×
avg
Mkt Cap
1.79B
USD
P/E
3.2
TTM
Div Yield
–
ann
52W Range
7th
pctl
Volume
1.02×
avg
Market Cap
1.79B
USD
P/E Ratio
3.2
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings